Combination therapy, or the use of multiple drugs, has been proven to be effective for complex diseases, but the differences in chemical properties and pharmacokinetics can be challenging in term of the loading, delivering, and releasing multiple drugs. Here we demonstrate that we can load and selectively release two different DNA oligonucleotides from two different gold nanorods. DNA was loaded on the nanorods via thiol conjugation. Selective releases were induced by selective melting of gold nanorods via ultrafast laser irradiation at the nanorods' longitudinal surface plasmon resonance peaks. Excitation at one wavelength could selectively melt one type of gold nanorods and selectively release one type 2 DNA strand. Releases were efficient (50-80%) and externally tunable by laser fluence. Released oligonucleotides were still functional. This proof of concept is potentially a powerful method for multiple-drug delivery strategies.
optical properties. 16, 17 Pulsed laser excitation in resonance with their longitudinal surface plasmon resonance (SPR long ) can heat NRs locally to high temperatures, 18 inducing melting. This triggered melting is exploitable for controlling the release of biomolecules conjugated to the NRs. 19 Since SPR long is tunable by changing NR aspect ratio (AR), NRs with different ARs can be excited independently at different wavelengths. If different NRs are conjugated to different molecules, this strategy could be utilized for orthogonal triggered release of multiple species. Others have utilized similar concept to independently control microfluidic valves using two different nanoparticles, gold colloids and gold nanoshells. 20 Here we demonstrate selective release of two distinct DNA strands from two different NRs by matching laser excitation wavelength to the NRs' SPR long (Scheme 1). We first demonstrate selective melting of two different NRs. Utilizing this concept, two different DNA oligonucleotides conjugated to each of the NRs were released selectively by irradiation at specific wavelengths, and released DNA was functional. The releases were also efficient (~50-80%) and externally controllable by tuning the laser fluence. Scheme 1. Overview of selective release. Laser irradiation of DNA-conjugated nanocapsules (blue ovals) and nanobones (red bones) are exposed to λ 800 irradiation (left), which melts the nanocapsules and selectively releases the conjugated DNA (labeled by FAM (green triangles)). Exposure to λ 1100 irradiation (right) melts the nanobones, selectively releasing the conjugated DNA (labeled by TMR (orange stars)).
RESULTS AND DISCUSSION
NRs were synthesized [21] [22] [23] to have distinct ARs and morphologies, with SPR long that overlapped with each of the laser excitation wavelengths. Short NRs, "nanocapsules," were ~11 nm × 44 nm, with <AR> = 4.0 ( Fig. 1a , inset) and SPR long at 800 nm ( Fig. 1b, black) , coinciding with the short wavelength excitation at ~800 nm (λ 800 ). Long NRs were bone-shaped ( Fig. 2a, inset) , presumably due to preferential deposition at the ends from the excess reducing agent. 21 "Nanobones" were ~17 × 89 nm with <AR> = 5.4 and SPR long at ~1100 nm ( Fig. 2b, black) , coinciding with the long wavelength excitation at 1100 nm (λ 1100 ). Size analysis was done utilizing ImageJ. 24 Mixtures allowed distinction between their populations by both the AR and morphology ( Fig. 3a) . TEM sizing of a mixture exhibited broader AR distribution due to overlapping peaks at 4.0 and 5.4. The 1.5 -2.0 AR peaks were from the small presence of synthesis byproducts (spheres, cubes, and stars). Spectral overlap of nanocapsules and nanobones at both excitation wavelengths was minimal ( Fig. 3b , black).
Figure 1.
Melting nanocapsules. a) AR histogram of nanocapsules exposed to irradiation at 800 nm at 1.68 mJ/cm 2 (blue) and 1100 nm at 1.73 mJ/cm 2 (red), and unexposed (black). TEM image of unexposed nanocapsules sample (inset). b) optical absorption spectra of nanocapsules upon exposure to λ 800 irradiation. Fluence (mJ/cm 2 ): 0 (black), 0.18 (red), 0.27 (green), 0.35 (blue), 0.70 (cyan), 1.06 (pink), 1.41 (orange), 1.68 (olive). Inset: TEM image of λ 800 irradiated sample with a fluence of 1.68 mJ/cm 2 . c) optical absorption of nanocapsules upon exposure to λ 1100 irradiation. Fluence (mJ/cm 2 ): 0 (black), 0.33 (red), 0.51 (green), 1.02 (blue), 1.39 (cyan), pink (1.73). Inset: TEM image of λ 1100 irradiated sample with a fluence of 1.73 mJ/cm 2 .
Figure 2.
Melting nanobones. a) AR histogram of nanobones exposed to irradiation at 800 nm at 1.68 mJ/cm 2 (blue) and 1100 nm at 1.73 mJ/cm 2 (red), and unexposed (black). TEM image of unexposed nanobones sample (inset). b) optical absorption spectra of nanobones upon exposure to λ 800 irradiation.
Fluence (mJ/cm 2 ): 0 (black), 0.18 (red), 0.27 (green), 0.35 (blue), 0.70 (cyan), 1.06 (pink), 1.41 (orange), 1.68 (olive). Inset: TEM image of λ 800 irradiated sample with a fluence of 1.68 mJ/cm 2 . c) optical absorption of nanobones upon exposure to λ 1100 irradiation. Fluence (mJ/cm 2 ): 0 (black), 0.33 (red), 0.51 (green), 1.02 (blue), 1.39 (cyan), pink (1.73). Inset: TEM image of λ 1100 irradiated sample with a fluence of 1.73 mJ/cm 2 . Figure 3 . Selective melting of nanocapsule/nanobone mixtures. a) AR histogram of nanocapsulesnanobones mixture exposed to irradiation at 800 nm at 1.68 mJ/cm 2 (blue) and 1100 nm at 1.73 mJ/cm 2 (red), and unexposed (black). Inset: TEM image of unexposed mixture. b) optical absorption spectrum of mixture after λ 800 irradiation. Fluence (mJ/cm 2 ): 0 (black), 0.18 (red), 0.27 (green), 0.35 (blue), 0.70 (cyan), 1.06 (pink), 1.41 (orange), 1.68 (olive). Inset: TEM image λ 800 irradiated mixture with a fluence of 1.68 mJ/cm 2 . c) optical absorption spectrum of mixture after λ 1100 irradiation. Fluence (mJ/cm 2 ): 0 (black), 0.33 (red), 0.51 (green), 1.02 (blue), 1.39 (cyan), pink (1.73). Inset: TEM image λ 1100 irradiated mixture with a fluence of 1.73 mJ/cm 2 .
Laser irradiation of gold NRs at SPR long caused melting, 18, 19 accompanied by a shape transformation to spheres. We studied the fluence dependence of nanocapsule and nanobone melting by monitoring absorption. λ 800 irradiation of nanocapsules caused the SPR long to decrease in intensity and blue-shift with increasing fluence, while the ~520 nm peak increased ( Fig. 1b ). This suggested that melting transformed nanocapsules into shorter rods and spheres. TEM images of nanocapsules after λ 800 irradiation (inset) and size analysis showed the AR distribution shift to lower values ( Fig. 1a , blue), supporting shape transformation to spheres. To show that melting of nanocapsules requires matching irradiation wavelength to the SPR long , we irradiated nanocapsules at 1100 nm. The absorption spectrum was unchanged ( Fig. 1c ), demonstrating no significant effect. TEMs of nanocapsules after λ 1100 irradiation (inset) were also unchanged, and size analysis showed little effect on the AR distribution ( Fig. 1a, red) .
The melting of the nanobones also required the matching of the irradiation wavelength to their SPR long . When nanobones were exposed to λ 1100 irradiation, the 1100 nm peak decreased and blueshifted with increasing fluence, while the ~520 nm peak increased ( Fig. 2c ). TEM imaging after λ 1100 irradiation confirmed a shape transformation into shorter "candy-wrap" or φ-shaped particles and spheres (inset). 25 Size analysis confirmed an AR shift to lower values ( Fig. 2a, red) . λ 800 irradiation had essentially no effect, as evidenced by no significant change in absorption scans ( Fig. 2b ). TEM after λ 800 irradiation (inset) and size analysis showed no significant changes in the AR distribution ( Fig. 2a , blue), indicating no shape transformation occurred.
We also selectively melted either the nanocapsules or nanobones when both were present in a mixture.
The absorption scan had peaks at 800 and 1100 nm due to the presence of both species, and TEMs and AR histograms showed both populations (Fig. 3a , black and inset). λ 800 irradiation caused the 800 nm peak to decrease, leaving the 1100 nm peak relatively unaffected (Fig. 3b ). After λ 800 irradiation, fewer nanocapsules were present relative to nanobones. Spheres appeared, resulting from the nanocapsule shape transformation (inset). The AR peak at 4.0 decreased in intensity, and peaks at 3.0 or less increased, suggesting melting to form spheres and shorter NRs (Fig. 3a , blue). However, the peak at 5.4 was relatively unchanged. These results support that λ 800 irradiation melted only the nanocapsules but not the nanobones. When the mixture was exposed to λ 1100 irradiation, the 1100 nm peak decreased with increasing fluence (Fig. 3c ) while the 800 nm peak increased, presumably due to shape transformation of nanobones into φ-shaped NRs, which are expected to absorb at wavelengths lower than 1100 nm. 25 TEM imaging after λ 1100 irradiation (inset) showed that the nanobones disappeared, with primarily nanocapsules, spheres, and φ−shaped NRs remaining. The AR peak at 5.4 decreased while peaks at 4.0 or less increased, indicating nanobone shape transformation ( Fig. 3a, red) . Evidently, λ 1100 irradiation affected only the nanobones and not nanocapsules. Thus, laser irradiation could selectively melt each species in a mixture, corroborating single-type NRs melting studies.
NRs were conjugated to thiolated DNA 40mers, which were each labeled with different fluorophores and thus distinguishable. Ligand exchange was necessary to avoid aggregation during DNA conjugation, and was performed prior to conjugation to replace the positively charged CTAB surfactant with negatively charged mercaptohexanoic acid. 26 The conjugations were done via charge screening methods. [26] [27] [28] Gel electrophoresis assayed DNA conjugation ( Fig. 4a-b ). Nanocapsules ran toward the positive electrode, indicating a negative charge from the mercaptohexanoic acid ligand coating the surface (Lane 1). Nanocapsules incubated with thiolated 6-carboxyfluorescein-labeled DNA 40mers (FAM-DNA-SH) were retarded, indicating a larger hydrodynamic radius due to conjugation (Lane 2).
The UV image of the gel (Fig. 4b ) showed that the free FAM-DNA-SH band after conjugation (Lane 2) was dimmer than the equal-concentration free FAM-DNA-SH alone (Lane 3), also supporting conjugation to nanocapsules, which quench fluorescence. Nanobones showed similar results for thiolated tetramethylrhodamine-labeled DNA 40mers (TMR-DNA-SH). The TMR-DNA-nanobones band (Lane 5) was retarded compared to nanobones alone (Lane 4), and the free TMR-DNA-SH band (Lane 5) was dimmer than the equal-concentration free TMR-DNA-SH alone (Lane 6). These results confirm DNA conjugation to both species. DNA loading on the NR surface was quantified by two methods. The fluorescence change of the supernatant with and without NRs measured the loss of free DNA that was due to NR conjugation. In addition, purified NRs conjugated to DNA were treated with high concentrations mercaptohexanol (MCH), which displaced conjugated DNA from the NR surface.
This displaced DNA was quantified by fluorescence. Both methods gave similar estimates of the DNA loadings, which was approximately 114 DNA/nanocapsule and 284 DNA/nanobone. 26, [29] [30] [31] Finally, the mixture of purified FAM-DNA-nanocapsules and TMR-DNA-nanobones was laser irradiated for selective release (Scheme 1). Exposure to laser irradiation was followed immediately by centrifugation, and released DNA in the supernatant was quantified by fluorescence spectroscopy. After λ 800 irradiation, the supernatant fluorescence at 520 nm increased with fluence ( Fig. 4c, solid lines) , illustrating FAM-DNA release. However, increased fluorescence at 580 nm was much lower, indicating insignificant TMR-DNA release (dashed lines). Therefore, λ 800 irradiation could selectively release FAM-DNA from nanocapsules, while leaving TMR-DNA-nanobones undisturbed. At fluences <1.00 mJ/cm 2 , FAM-DNA release was selective, reaching ~70 % while TMR-DNA release was ≤ 10 %, where 100% was the amount released by MCH treatment (Fig. 4e ). For fluences > 1.00 mJ/cm 2 , release of TMR-DNA from nanobones did increase, while FAM-DNA release was saturated. When the mixture was exposed to λ 1100 irradiation, supernatant fluorescence at 580 nm increased ( Fig. 4d, dashed lines) , while intensity at 520 nm was negligible (solid lines), illustrating TMR-DNA release with no significant FAM-DNA release. TMR-DNA release was selective, reaching 50 -60% while FAM-DNA release was < 10% (Fig. 4f ). Therefore, λ 1100 irradiation could selectively release TMR-DNA from nanobones, while leaving FAM-DNA-nanocapsules undisturbed. Evidently, the NRs undergo a shape transformation at these fluences ( Figs. 1-3) , which probably induces release due to gold-thiol bond dissociation. 32, 33 We observed that re-adsorption of the released DNA back onto the melted gold nanorods after a long period of time (3 months) was minimal (Fig. S1, Supporting Information) . We also observed that the laser irradiation had no effect on the fluorescence of the FAM-DNA and TMR-DNA (Fig. S2, Supporting Information).
We confirmed that released DNA was still functional and could hybridize to a complement. Released DNA was incubated with DABCYL-functionalized DNA complements, and hybrid formation confirmed by melting curves. Dequenching of FAM at 520 nm (Fig. 4e , inset) and TMR at 585 nm ( Fig.   4f inset) was monitored with increasing temperature. Both curves were characteristic of functional hybrids, with T m 's coinciding with that of the plain DNA (T m = 42 °C).
In conclusion, we demonstrate selective release of two distinct DNA oligonucleotides from two different NRs via selective laser-induced melting of NRs. Because laser fluence governs the degree of NR melting, yield and specificity of DNA release, the controlled releases are externally tunable. Tuning NR synthesis parameters could extend this approach beyond two species. Since conjugation requires only standard thiol conjugation, it is potentially applicable to a wide range of molecules. NRs have relatively large surface area and the capacity to loads hundreds of molecules, and ~80% of the payload can be released. NRs are chemically versatile, with customizable coatings, and others have demonstrated active targeting by decorating the NRs with moieties such as antibodies and cell receptor ligands. Others have also utilized laser-induced melting of a single type of NR for controlled release inside cells, while maintaining cell viability by tuning the laser parameters appropriately. 19 Therefore, this proof of concept triggered release from NRs is potentially a powerful technique for improving drug delivery strategies.
METHODS

GOLD NANOROD SYNTHESIS
Both nanocapsules and nanobones were synthesized using the seed-mediated growth method. The preparation of the seed solution was the same for both. Typical protocol: 7.5 ml of 0.2 M CTAB solution was mixed with 0.25ml 0.01M HAuCl 4 (for nanocapsules) or 2.5 ml 0.001 M HAuCl 4 (for nanobones) in a beaker. While the solution was vigorously stirred, 0.6 ml of ice-cold 0.01 M of NaBH 4 was added and the solution turned brownish yellow. Vigorous stirring continued for another 2 min and then it was kept undisturbed at room temperature. Nanocapsules were synthesized by single-surfactant seed-mediated growth method. 23 
NANOROD CHARACTERIZATION
Nanorod concentrations were quantified by optical absorption using estimated extinction coefficients. 30 Cary 500 UV-VIS-NIR Spectrophotometer (Varian Inc.) was used to scan the absorption profiles of NRs solutions. Based on their SPR long , we estimated the extinction coefficients to be 4.6 x 10 9 M -1 cm -1 and 8.6 x 10 9 M -1 cm -1 for nanocapsules and nanobones respectively. TEM imaging was done on a JEOL 2010 using holey carbon grids. Size analysis was done utilizing ImageJ. 24 
LIGAND EXCHANGE OF NANORODS
The CTAB surfactant on the NR surface was replaced with mercaptohexanoic acid (MHA) by roundtrip phase transfer ligand exchange as described in detail in previous work. 26 First we performed aqueous-to-organic phase transfer. Concentrated NR with CTAB surfactants (NR-CTAB) in water was put into contact with dodecanethiol (DDT). After addition of acetone, NRs were extracted into DDT by swirling the solution for a few seconds, upon which the aqueous phase became clear, indicating that no NRs remained. Next, organic-to-aqueous phase transfer was performed. To remove the excess DDT, the DDT coated NRs (NR-DDT) was diluted in toluene. Centrifugation was performed to collect the NR-DDT. Methanol may be needed to precipitate the NR-DDT prior to centrifugation. The collected NR-DDT was resuspended in 1 of mL toluene by brief sonication. The NR-DDT in toluene was then added to 9 mL of 0.01 M mercaptohexanoic acid (MHA) in toluene at 95 °C and vigorously stirred. Reflux and stirring continued until visible aggregation was observed (within ~15 min), and then the solution was allowed to settle and cool to room temperature. Aggregation indicated that NRs were successfully coated by MHA, which are insoluble in toluene. The aggregates were washed 2× with toluene via decantation and then once with isopropanol to deprotonate the carboxylic acid. The aggregates spontaneously redispersed in 1× tris-borate-EDTA buffer (TBE) and were no longer soluble in toluene.
This ligand exchange protocol was performed for both types of NR (nanocapsules and nanobones).
DNA FUNCTIONALIZATION OF NANORODS
40mers DNA oligonucleotides with sequences 5' HS-TTTTT TTTTT TTTTT TTTTT TTTTT TCGGC CCGTA TAATT 3', fluorescently labeled at the 3' ends with either 6-carboxyfluorescein (FAM-DNA-SH) or tetramethylrhodamine (TMR-DNA-SH), were purchased from Sigma Aldrich.
DNA conjugation was achieved following charge screening protocols. [26] [27] [28] Charge screening (salt-aging) was necessary to compensate for electrostatic repulsion between the negatively charged ligand Two methods were used to confirm NR-DNA conjugation. First, gel electrophoresis was used to observe mobility changes to assay any change in the hydrodynamic radius of DNA-conjugated NRs. Gel electrophoresis was performed with 0.5 % agarose gels in 0.5× TBE. Glycerol was used for loading the samples to ensure the nanorods stayed in the wells prior to traveling in the gel matrix.
The second method to confirm the conjugation was quantification of the DNA loading onto the NR surface. This was accomplished by two methods. First, we quantified the free unconjugated DNA via fluorescence spectroscopy of the fluorophore labels (FAM for nanocapsules and TMR for nanobones) with or without nanorods present. This was done by collecting the supernatants after centrifugation of the conjugation solution. The second method was accomplished by chemical displacement of the conjugated DNA using literature methods. 26, 31 Briefly, purified NR-DNA conjugates were incubated in 1 mM mercaptohexanol (MCH) overnight; displacing the DNA from the NRs. Free displaced DNA was separated from the NRs by centrifugation and quantified by fluorescence spectroscopy. Both methods gave similar estimates of the DNA loadings of approximately 114 DNA/nanocapsule and 284 DNA/nanobone. 30 
LASER IRRADIATION
Laser irradiation was achieved using pulsed femtosecond lasers. For the 800 nm irradiation, the 82 MHz output of a Ti:sapphire oscillator (Tsunami, Spectra-Physics) is amplified at 1 kHz by a Ti:sapphire regenerative amplifier (Spitfire, Spectra-Physics) pumped by the doubled output of a Qswitched Nd:YLF laser (Empower, Spectra-Physics). The system produces 50 -475 μJ, with duration of 100 fs centered at ~800 nm at a 1 kHz repetition rate. Spot size was 6 mm. Two filter lenses (900 nm shortpass and 700 nm longpass) were placed prior to the sample holder. In a typical experiment, 50 μL of sample in 3x3mm quartz cuvette was exposed to laser for 60 s.
The 1100 nm was generated via a homebuilt two-stage BBO/KNbO 3 optical parametric amplifier pumped with the output of a Ti:Sapphire multipass amplifier (Femtolasers: 30 fs, 1 kHz, 800nm).
Although the OPA is optimized for the production of 3μm light, ~2.6 -13.6 μJ pulses of 1100nm light were generated, the difference frequency between 800 nm and 3 μm, is generated by the OPA and used for the experiments. The generated ~1100nm has duration of 45 fs/pulse with repetition rate of 1 kHz.
Spot size was 1 mm. 900 nm longpass filter lens was placed prior to the sample holder. In typical experiments, 50 μL of sample in 3×3 mm quartz cuvette were continuously mixed with pipette tip while being exposed to laser for 60 s.
In the NR melting study we had three samples: nanocapsules, nanobones, and a mixture of both. They were all suspended in a 10 mM CTAB solution. The concentration of nanocapsules sample was ~0.8 nM. The concentration of the nanobones sample was ~0.4 nM. The concentrations of the mixture were ~0.4 nM and ~0.2 nM for the nanocapsules and nanobones respectively. After 800 nm or 1100 nm laser exposure, samples were diluted with 150 μL of a 10 mM CTAB solution. UV-vis-NIR absorption scans were performed for monitoring their shape transformations.
In the DNA release study, we used a mixture of FAM-DNA-nanocapsules and TMR-DNA-nanobones with concentrations of ~0.4 nM and ~0.2 nM, respectively, in 1× TBE. Samples were washed ≥ 3× with 1× TBE to remove free DNA prior to mixing. After 800 nm or 1100 nm laser exposure, samples were immediately diluted with 150 μL of 1× TBE and followed by centrifugation at 16,100 g for 5 min to remove the NRs and collect the supernatants. Fluorescence spectroscopy was used to quantify the released DNA in supernatants. We quantified the fluorescence intensity of FAM due to FAM-DNA released from nanocapsule and TMR due to TMR-DNA released from nanobones.
To ensure that the released DNA from both nanocapsules and nanobones were still functional, we hybridized them with their complement. The complement was functionalized with a 5' DABCYL (5' DABCYL-AATTATACGGGCCG 3') to quench the FAM and TMR in the hybridized state. Melting curves were obtained in a temperature controlled Peltier module of the fluorescence spectrometer, where the increase of fluorescence of either FAM or TMR was monitored as a function of increasing temperature.
